ST
S. Edward Torres
10% Owner

S. Edward Torres insider trades: Surface Oncology (SURF) stock buys and sales

10% Owner, Surface Oncology Last trade Apr 23, 2018 20 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
15
Open-market trades
since 2013
5
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where S. reports to the SEC

Open-market buys and sales

15 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 23, 2018SURF↑ Buy$4.0M
Jul 5, 2017ALRN↑ Buy$3.8M
Aug 16, 2016PTGX↑ Buy$7.0M
Mar 17, 2016GBIM↓ Sell$44K
Jun 16, 2015RCPT↓ Sell$39.4M
Feb 27, 2015RCPT↓ Sell$937K
Feb 23, 2015RCPT↓ Sell$3.4M
Feb 23, 2015RCPT↓ Sell$6.1M
Sep 23, 2014RCPT↓ Sell$6.1M
Sep 19, 2014RCPT↓ Sell$18.8M
Aug 13, 2014RCPT↓ Sell$8.6M
Jul 8, 2014GBIM↑ Buy$850K
May 21, 2014RCPT↓ Sell$10.7M
May 15, 2014RCPT↓ Sell$2.5M
May 14, 2013RCPT↑ Buy$2.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About S. Edward Torres's insider trades

S. Edward Torres is a 10% owner of Surface Oncology (SURF). Since May 14, 2013, S. has reported 5 open-market purchases worth $17.6M and 10 sales worth $96.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include conversions (5 filings), grants and awards (4 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SURF insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.